Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling.
Saved in:
| Title: | Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling. |
|---|---|
| Authors: | Farrell M; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States.; Tufts University School of Medicine, Boston, United States., Fairfield H; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States.; Tufts University School of Medicine, Boston, United States., Karam M; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States., D'Amico A; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States., Murphy CS; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States., Falank C; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States., Pistofidi RS; Dana-Farber Cancer Institute, Boston, United States.; Harvard Medical School, Boston, United States., Cao A; Dana-Farber Cancer Institute, Boston, United States.; Harvard Medical School, Boston, United States., Marinac CR; Dana-Farber Cancer Institute, Boston, United States.; Harvard Medical School, Boston, United States., Dragon JA; University of Vermont, Burlington, United States., McGuinness L; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; University of New England, Biddeford, United States., Gartner CG; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States.; Tufts University School of Medicine, Boston, United States., Iorio RD; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; University of New England, Biddeford, United States., Jachimowicz E; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States., DeMambro V; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States., Vary C; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States.; Tufts University School of Medicine, Boston, United States., Reagan MR; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States.; Tufts University School of Medicine, Boston, United States. |
| Source: | ELife [Elife] 2023 Mar 07; Vol. 12. Date of Electronic Publication: 2023 Mar 07. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
